165 related articles for article (PubMed ID: 37308125)
1. Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Azad N; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Hecht JR; Hoffe S; Hubbard J; Hunt S; Hussan H; Jeck W; Johung KL; Joseph N; Kirilcuk N; Krishnamurthi S; Maratt J; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stotsky-Himelfarb E; Tavakkoli A; Willett CG; Williams G; Algieri F; Gurski L; Stehman K
J Natl Compr Canc Netw; 2023 Jun; 21(6):653-677. PubMed ID: 37308125
[TBL] [Abstract][Full Text] [Related]
2. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Freedman-Cass DA
J Natl Compr Canc Netw; 2018 Jul; 16(7):852-871. PubMed ID: 30006428
[TBL] [Abstract][Full Text] [Related]
3. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
Benson AB; Arnoletti JP; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Dilawari RA; Engstrom PF; Enzinger PC; Fakih MG; Fleshman JW; Fuchs CS; Grem JL; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett C; Freedman-Cass DA;
J Natl Compr Canc Netw; 2012 Apr; 10(4):449-54. PubMed ID: 22491045
[TBL] [Abstract][Full Text] [Related]
4. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R; Nilsson PJ; Aschele C; Goh V; Peiffert D; Cervantes A; Arnold D; ; ;
Eur J Surg Oncol; 2014 Oct; 40(10):1165-76. PubMed ID: 25239441
[TBL] [Abstract][Full Text] [Related]
5. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system.
Tarantino D; Bernstein MA
Dis Colon Rectum; 2002 Jan; 45(1):16-22. PubMed ID: 11786758
[TBL] [Abstract][Full Text] [Related]
6. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R; Nilsson PJ; Aschele C; Goh V; Peiffert D; Cervantes A; Arnold D; ; ;
Radiother Oncol; 2014 Jun; 111(3):330-9. PubMed ID: 24947004
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and Therapy of Anal Carcinoma].
Radke A; Beyer J
Praxis (Bern 1994); 2022 Feb; 110(2):89-96. PubMed ID: 35105214
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
9. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
10. Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
Khawandanah M; Baxley A; Pant S
J Oncol Pharm Pract; 2015 Jun; 21(3):232-7. PubMed ID: 24627343
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of inguinal lymph node recurrence after chemo-radiation for anal canal squamous carcinoma].
Murata K; Okamura S; Wada Y; Makino S; Kato R; Nishigaki T; Owada Y; Murakami M; Okada K; Ebisui C; Yokouchi H; Kinuta M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2275-7. PubMed ID: 23268048
[TBL] [Abstract][Full Text] [Related]
12. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Koh WJ; Greer BE; Abu-Rustum NR; Campos SM; Cho KR; Chon HS; Chu C; Cohn D; Crispens MA; Dizon DS; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; Han E; Higgins S; Huh WK; Lurain JR; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Ueda S; Valea FA; Wyse E; Yashar CM; McMillian N; Scavone J
J Natl Compr Canc Netw; 2017 Jan; 15(1):92-120. PubMed ID: 28040721
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
[TBL] [Abstract][Full Text] [Related]
15. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Chang S; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Guzzo T; Herr HW; Hoffman-Censits J; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Michalski J; Montgomery JS; Nandagopal L; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wright JL; Gurski LA; Johnson-Chilla A
J Natl Compr Canc Netw; 2020 Mar; 18(3):329-354. PubMed ID: 32135513
[TBL] [Abstract][Full Text] [Related]
16. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
17. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
[TBL] [Abstract][Full Text] [Related]
18. A Pattern of Care Report on the Management of Patients with Squamous Cell Carcinoma of the Anus-A Study by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Tumors Study Group.
Franco P; Chiloiro G; Montesi G; Montrone S; Arcelli A; Comito T; Arcadipane F; Caravatta L; Macchia G; Lupattelli M; Niespolo MR; Munoz F; Palazzari E; Krengli M; Valvo F; Gambacorta MA; Genovesi D; Mantello G
Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946287
[No Abstract] [Full Text] [Related]
19. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Squamous Cell Carcinoma Anal Canal treated with IMRT-VMAT-based Concurrent Chemoradiation: a Single Institutional Experience.
Singh K; Sathyamurthy A; Ramireddy JK; Ram TS
J Gastrointest Cancer; 2022 Mar; 53(1):161-169. PubMed ID: 33400211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
